Dr. Kelly's presentation on potential cancer indications

New Post Public Reply Private Reply Replies (1) Message Board
melsdollars
725
Dr. Kelly's presentation on potential cancer indications for leronlimab was great. One nugget of info we didn't have previously was that CYDY is now cleared to use the 700mg dose for the cancer patients. That is extremely good news! We will likely see even better results!

The photos of the tumors with blood vessels were very interesting. It was amazing to see how Leronlimab disrupted and destroyed their blood vessels. Without blood supply, tumors will not grow and will eventually die. Outstanding.

I thought Dr. Kelly did a great job presenting. He was clear, concise and authoritative. I wish we could have heard the follow up questions but I understand that some of the information exchanged may be confidential.

Here's the link to the presentation in case you haven't seen it yet. https://d1io3yog0oux5.cloudfront.net/cytodyn/...vr0qX6q_Ds

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

NVIDIA Announces Details for Upcoming Q3 Financial Call

Updated Category News Views 84

NVIDIA's Conference Call for Third-Quarter Financial Results NVIDIA is preparing to host a conference call where the company's financial results for the third quarter will be addressed. This call is scheduled for Wednesday, November 20, at 2 p.m. PT, allowing both analysts and investors an opportunity to understand the company's performance in a detailed manner. Live...

Continue Reading
Endeavour Mining's Recent Share Buyback and Market Position

Updated Category News Views 165

Endeavour Mining Conducts Share Buyback Endeavour Mining plc, a leading gold producer, has recently undertaken a strategic initiative by purchasing its own shares in the market. This move signifies a strong commitment to enhancing shareholder value and reflects the company’s robust financial posture. Overview of the Shares Purchased The company acquired a total of...

Continue Reading
Embark on Luxurious Train Journeys Across China’s Landscapes

Updated Category News Views 116

Unveiling the Train of Glamour Experience Journey Beyond the Ordinary: The Train is The Destination Welcome aboard the Train of Glamour, a luxurious travel experience that redefines railway tourism in China. With an expanded route schedule in 2025, the Train of Glamour offers travelers a unique opportunity to explore breathtaking Chinese landscapes and diverse cultures....

Continue Reading
Important Alert for Flywire Investors Amid Legal Proceedings

Updated Category News Views 142

Critical Information for Flywire Corporation Investors If you have invested in Flywire Corporation (NASDAQ: FLYW) and experienced financial losses, it’s essential to pay attention to the upcoming deadline for a class action lawsuit. The Law Offices of Frank R. Cruz is reaching out to inform you of your rights regarding your investment losses and the ongoing litigation...

Continue Reading
Exploring Promising Biotech Stocks for Future Growth Opportunities

Updated Category News Views 94

Innovating in Biotechnology: A Bright Future Ahead The biotechnology sector is witnessing a remarkable transformation, largely fueled by advancements in artificial intelligence (AI). Companies are now leveraging machine learning to effectively identify drug targets, enhance molecular structures, and make accurate predictions regarding clinical trial outcomes. This...

Continue Reading